Also trades as: ACST.V (TSXV) · $vol 0M
ACST NASDAQ
Acasti Pharma Inc.
1W: +5.5%
1M: -3.5%
3M: +38.4%
1Y: +56.9%
3Y: -62.6%
5Y: -96.7%
$3.37
Last traded 2024-11-22 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$9M
+40.5% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$9M
+40.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5M
-491.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$10M | -$42M | -$13M | -$13M | -$8M |
| Depreciation & Amort. | $0 | $124K | $11K | $7K | $7K |
| Stock-Based Comp. | $1M | $2M | $913K | $730K | $798K |
| Change in Working Capital | -$3M | $181K | -$1M | $0 | $0 |
| Other Non-Cash Items | -$5M | $34M | $3M | $325K | -$181K |
| Operating Cash Flow | -$17M | -$16M | -$12M | -$15M | -$9M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$17K | -$22K | $0 | $0 |
| Acquisitions (Net) | $0 | $5M | $0 | $0 | $0 |
| Investment Purchases | -$35M | -$5M | -$7M | -$15K | $0 |
| Investment Sales | $31M | $18M | $7M | $15K | $0 |
| Other Investing | -$4K | -$5M | $0 | $0 | $0 |
| Investing Cash Flow | -$4M | $13M | $104K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $21K | $14M | $4M |
| Financing Cash Flow | $0 | $304K | $7M | $14M | $4M |
| Net Change in Cash | -$21M | -$2M | -$5M | -$872K | -$5M |
| Cash End of Period | $30M | $28M | $23M | $22M | $17M |
| Free Cash Flow | -$17M | -$16M | -$12M | -$15M | -$9M |